Literature DB >> 6125174

Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.

O Thulesius, J E Gjöres, E Berlin.   

Abstract

1 In vitro experiments have been performed using 33 preparations of human arteries and veins and 10 human umbilical artery preparations. Changes in the tone of helical strips of vasculature were recorded isometrically following contraction of the tissues by exposure to 5-hydroxytryptamine (10(-6)--10(-5) M) or potassium (127 mM). 2 Isoprenaline included concentration-dependent relaxation and this effect could be competitively antagonized by propranolol or sotalol. 3 The beta-adrenoceptor antagonists pindolol and celiprolol, both of which possess intrinsic sympathomimetic activity, produced concentration-dependent relaxations of arteries and veins but not of umbilical vessels. 4 The relaxation produced by pindolol or celiprolol could be antagonized but not abolished by pretreatment with propranolol or sotalol. 5 It is concluded that the vascular relaxation produced by beta-adrenoceptor antagonists with intrinsic sympathomimetic activity is the result of beta 2-adrenoceptor stimulation. In the case of pindolol the relaxant effects were seen at concentrations within the range encountered after administration of normal therapeutic doses suggesting that this effect may contribute to the haemodynamic responses to pindolol seen in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125174      PMCID: PMC1402160          DOI: 10.1111/j.1365-2125.1982.tb01917.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  2 in total

1.  Determination of pindolol in human plasma by high-performance liquid chromatography.

Authors:  M Bangah; G Jackman; A Bobik
Journal:  J Chromatogr       Date:  1980-08-08

2.  Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.

Authors:  J H Atterhög; H Dunér; B Pernow
Journal:  Acta Med Scand       Date:  1977
  2 in total
  11 in total

Review 1.  Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.

Authors:  Charles Khouri; Thomas Jouve; Sophie Blaise; Patrick Carpentier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-05-31       Impact factor: 4.335

Review 2.  Do partial agonist beta-blockers have improved clinical utility?

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 3.  Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.

Authors:  G Sponer; W Bartsch; K Strein
Journal:  Clin Investig       Date:  1992

4.  Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.

Authors:  C de Mey; K Beithaupt; D Palm; U Fuhr; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.

Authors:  B Silke; A Thompson; A Leitch; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

6.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors:  B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.

Authors:  A Svensson; T Gudbrandsson; R Sivertsson; L Hansson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 9.  A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.

Authors:  M J Kendall; I Rajman
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 10.  Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.

Authors:  J G Riddell; R G Shanks; R N Brogden
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.